Prof. Jeroen Raes

KOL Gut Microbiome, VIB-KU Leuven

Therapeutic Areas

Drug	Indication	Phase
MH002	Ulcerative Colitis (mild-to-moderate)	Phase 2a
Preclinical Programs	Other Inflammatory Diseases	Preclinical